Exubera

Pfizer's offering, called Exubera, won FDA approval in 2006 before the company pulled it off the market after patients showed little interest in using its bonglike inhaler.

Billionaire Al Mann's Quest For A Diabetes Breakthrough David Whelan 2010

Pfizer's offering, called Exubera, won FDA approval in 2006 before the company pulled it off the market after patients showed little interest in using its bonglike inhaler.

Billionaire Al Mann's Quest For A Diabetes Breakthrough David Whelan 2010

Pfizer Inc. pulled out of its partnership to sell an insulin inhaler called Exubera in October, taking a $2.8 billion charge.

Eli Lilly Drops Inhalable-Insulin Product 2008

Pfizer Inc. pulled out of its partnership to sell an insulin inhaler called Exubera in October, taking a $2.8 billion charge.

Alkermes to Cut Jobs, Close Plant 2008

Pfizer shares are trading higher after a judge rejected Novo Nordisk's request that Pfizer halt sales of its insulin product Exubera, which is inhaled.

On The Move For Thursday, Dec. 14 2006

One inhaled insulin, called Exubera, was actually approved by the FDA in 2006, but it failed to generate sufficient sales and was pulled from the market by Pfizer the next year.

chicagotribune.com - 2010

It maybe too premature to speak about how the product will finally look like, but absorption of oral inhale form of insulin been a question and that's why many years ago 'Exubera', which was Pfizer's drug, was also withdrawn.

Moneycontrol Top Headlines 2010

It maybe too premature to speak about how the product will finally look like, but absorption of oral inhale form of insulin been a question and that's why many years ago 'Exubera', which was Pfizer's drug, was also withdrawn.

Moneycontrol Top Headlines 2010

Their product offers definite advantages over the failed inhalable insulins such as Exubera, and I actually have come to hope they succeed so diabetics later have greater choices for administering their required insulin.

Generex Taps Former Eli Lilly Medical Director to Strengthen Clinical and Regulatory Efforts - Seeking Alpha 2010

Pfizer spent a decade testing a new inhaled form of insulin called Exubera.

Medical Flops Of The Decade 2010